Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer
- PMID: 16243810
- DOI: 10.1158/1078-0432.CCR-05-1100
Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer
Abstract
Purpose: Repetitive ribosomal DNA (rDNA) genes are GC-rich clusters in the human genome. The aim of the study was to determine the methylation status of two rDNA subunits, the 18S and 28S genes, in ovarian tumors and to correlate methylation levels with clinicopathologic features in a cohort of ovarian cancer patients.
Experimental design: 18S and 28S rDNA methylation was examined by quantitative methylation-specific PCR in 74 late-stage ovarian cancers, 9 histologically uninvolved, and 11 normal ovarian surface epithelial samples. In addition, methylation and gene expression levels of 18S and 28S rDNAs in two ovarian cancer cell lines were examined by reverse transcription-PCR before and after treatment with the demethylating drug 5'-aza-2'-deoxycytidine.
Results: The methylation level (amount of methylated rDNA/beta-actin) of 18S and 28S rDNAs was significantly higher (P < 0.05) in tumors than in normal ovarian surface epithelial samples. Methylation of 18S and 28S rDNA was highly correlated (R2= 0.842). Multivariate analysis by Cox regression found that rDNA hypermethylation [hazard ratio (HR), 0.25; P < 0.01], but not age (HR, 1.29; P = 0.291) and stage (HR, 1.09; P = 0.709), was independently associated with longer progression-free survival. In ovarian cancer cell lines, methylation levels of rDNA correlated with gene down-regulation and 5'-aza-2'-deoxycytidine treatment resulted in a moderate increase in 18S and 28S rDNA gene expressions.
Conclusion: This is the first report of rDNA hypermethylation in ovarian tumors. Furthermore, rDNA methylation levels were higher in patients with long progression-free survival versus patients with short survival. Thus, rDNA methylation as a prognostic marker in ovarian cancer warrants further investigation.
Similar articles
-
Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.Int J Mol Med. 2011 May;27(5):625-35. doi: 10.3892/ijmm.2011.640. Epub 2011 Mar 3. Int J Mol Med. 2011. PMID: 21373750
-
Can the rDNA methylation pattern be used as a marker for Alzheimer's disease?Alzheimers Dement. 2008 Nov;4(6):438-42. doi: 10.1016/j.jalz.2008.03.010. Alzheimers Dement. 2008. PMID: 19012869
-
Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker.Cancer. 2002 Jun 1;94(11):2941-52. doi: 10.1002/cncr.10559. Cancer. 2002. PMID: 12115383
-
Structure and organization of ribosomal DNA.Biochimie. 1991 Jun;73(6):631-8. doi: 10.1016/0300-9084(91)90042-y. Biochimie. 1991. PMID: 1764510 Review.
-
Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis.Medicine (Baltimore). 2019 Feb;98(8):e14588. doi: 10.1097/MD.0000000000014588. Medicine (Baltimore). 2019. PMID: 30813180 Free PMC article. Review.
Cited by
-
H3K9 Demethylation-Induced R-Loop Accumulation Is Linked to Disorganized Nucleoli.Front Genet. 2020 Feb 6;11:43. doi: 10.3389/fgene.2020.00043. eCollection 2020. Front Genet. 2020. PMID: 32117455 Free PMC article.
-
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients.Cells. 2020 Nov 3;9(11):2409. doi: 10.3390/cells9112409. Cells. 2020. PMID: 33153169 Free PMC article.
-
MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer.BMC Cancer. 2010 Apr 29;10:173. doi: 10.1186/1471-2407-10-173. BMC Cancer. 2010. PMID: 20429937 Free PMC article.
-
Human rDNA and Cancer.Cells. 2021 Dec 8;10(12):3452. doi: 10.3390/cells10123452. Cells. 2021. PMID: 34943960 Free PMC article. Review.
-
Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.Epigenetics. 2011 Jun;6(6):727-39. doi: 10.4161/epi.6.6.15856. Epub 2011 Jun 1. Epigenetics. 2011. PMID: 21540640 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous